Skip to content
FineHeart logo — Propelling the future of cardiovascular care with groundbrea...

FineHeart

Propelling the future of cardiovascular care with groundbreaking medical advancements.

Founded 2010 51-200 employees Series C Total: $44.91M Biotechnology, Health Care +1

General Information

Company Name FineHeart
Founded Year 2010
Employees 51-200
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with FineHeart. To contact FineHeart, visit fineheart.fr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does FineHeart compare?

A PDF of FineHeart and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting FineHeart soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About FineHeart

FineHeart, a France-based medical device company established in 2010, is making strides in the cardiovascular space with innovative technologies. With the recent €15.00M Series C investment on 19 October 2022 from the European Innovation Council, FineHeart is poised to advance cardiovascular care. The company's goal of financing the development of its inaugural product aligns with its mission to propel the future of cardiovascular care. As a player in the biotechnology, health care, and medical devices industries, FineHeart is positioning itself as a key contributor to groundbreaking medical advancements.

Business keywords: medical device company, cardiovascular care, innovative technologies, cardiac assistance, implantable cardiac output management system, mechatronic medicine, heart failure

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €2.50M 1
European Innovation Council
19 Oct 2022
Series C €15.00M 1
European Innovation Council
19 Oct 2022
Series B €21.00M 8
Broadview Ventures, Verve Ventures +6
01 Jun 2021
Series A €6.41M -
22 Mar 2016

FineHeart Alternatives & Competitors

View All Alternatives
FineHeart vs

Presenting the ModulHeart. Low-risk heart support for patients with advanced heart failure

Series A
32 employees
Health Care, Medical Devices
FineHeart vs
EBR Systems, Inc.
EBR Systems, Inc. United States

Overcoming the limitations of conventional CRT through Wireless, LV Endocardial Pacing

Private Equity
89 employees
Biotechnology, Health Care
FineHeart vs
CVRx | Barostim
CVRx | Barostim United States

CVRx’s Barostim is a breakthrough technology that stimulates the body’s natural baroreflex to treat...

Private Equity
246 employees
Biotechnology, Health Care

FAQ About FineHeart

Propelling the future of cardiovascular care with groundbreaking medical advancements.
FineHeart was founded in 2010.
FineHeart operates in Biotechnology, Health Care and Medical Devices. Its work centres on medical device company, cardiovascular care, innovative technologies and cardiac assistance.
FineHeart has approximately 51-200 employees.
FineHeart has completed 4 funding rounds, raising a total of $44.91M. The latest funding stage is Series C.
Top alternatives and competitors to FineHeart include Puzzle Medical Devices Inc., EBR Systems, Inc., CVRx | Barostim, BMEYE, The Texas Heart Institute. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
FineHeart and Puzzle Medical Devices Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for FineHeart, https://bouncewatch.com/company/fineheart-1, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout